Clinical Trials Browser

Phase 2 × Aspirin × Plasma cell × Clear all

NCT00482261 2024-11-08

A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression

Phase 2 Completed

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT00691704 2014-08-19

Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy

Phase 2 Completed

18 enrolled 12 charts

Multiple Myeloma